• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

特刊“癌症免疫治疗的分子进展”

Special Issue "Molecular Advances in Cancer Immunotherapy".

作者信息

Schaft Niels

机构信息

Department of Dermatology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.

Comprehensive Cancer Center Erlangen European Metropolitan Area of Nuremberg (CCC ER-EMN), 91054 Erlangen, Germany.

出版信息

Int J Mol Sci. 2025 Nov 8;26(22):10839. doi: 10.3390/ijms262210839.

DOI:10.3390/ijms262210839
PMID:41303327
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12652641/
Abstract

Cancer immunotherapy is defined as a type of cancer treatment that helps the immune system recognize and attack cancer cells more effectively [...].

摘要

癌症免疫疗法被定义为一种癌症治疗方式，它能帮助免疫系统更有效地识别和攻击癌细胞[……]。

相似文献

1
Special Issue "Molecular Advances in Cancer Immunotherapy".特刊“癌症免疫治疗的分子进展”
Int J Mol Sci. 2025 Nov 8;26(22):10839. doi: 10.3390/ijms262210839.
2
Special Issue: "Advances in Immunotherapy for Cancer: From Molecular Basis to Novel Biomarkers and Therapeutic Targets".
Int J Mol Sci. 2025 Oct 5;26(19):9696. doi: 10.3390/ijms26199696.
3
Introduction to the special issue-Barriers and opportunities to cancer immunotherapy in the tumor immune microenvironment.特刊介绍——肿瘤免疫微环境中癌症免疫治疗的障碍与机遇
Semin Immunol. 2020 Jun;49:101421. doi: 10.1016/j.smim.2020.101421. Epub 2020 Dec 9.
4
Local delivery of checkpoints antibodies.检查点抗体的局部递送。
Hum Vaccin Immunother. 2017 Jan 2;13(1):245-248. doi: 10.1080/21645515.2016.1223000. Epub 2016 Sep 26.
5
Cancer immunotherapy.癌症免疫疗法
Crit Rev Clin Lab Sci. 2009;46(4):167-89. doi: 10.1080/10408360902937809.
6
In this issue: Role of immune cells, immune modulating factors and immunotoxins in cancer immunotherapy.本期内容：免疫细胞、免疫调节因子及免疫毒素在癌症免疫治疗中的作用。
Int Rev Immunol. 2017 Jul 4;36(4):205-206. doi: 10.1080/08830185.2017.1326784. Epub 2017 May 24.
7
Cancer immunotherapy: harnessing the immune system to battle cancer.癌症免疫疗法：利用免疫系统对抗癌症。
J Clin Invest. 2015 Sep;125(9):3335-7. doi: 10.1172/JCI83871. Epub 2015 Sep 1.
8
Special Issue "Cancer Immunotherapy: Tumor Microenvironment, Biomarker Discovery and Immune Resistance".特刊征稿：癌症免疫疗法：肿瘤微环境、生物标志物发现和免疫抵抗
Int J Mol Sci. 2024 May 8;25(10):5113. doi: 10.3390/ijms25105113.
9
Cancer Immunotherapy: An Updated Overview of Current Strategies and Therapeutic Agents.癌症免疫疗法：当前策略与治疗药物的最新概述
Gulf J Oncolog. 2019 Jan;1(29):76-82.
10
Genomics-Guided Immunotherapy for Precision Medicine in Cancer.基于基因组学的免疫治疗在癌症精准医学中的应用。
Cancer Biother Radiopharm. 2019 Oct;34(8):487-497. doi: 10.1089/cbr.2018.2758. Epub 2019 Jul 16.

本文引用的文献

1
Tumour-infiltrating lymphocyte therapy comes of age in the era of genetic engineering.在基因工程时代，肿瘤浸润淋巴细胞疗法已走向成熟。
Lancet Oncol. 2025 Nov;26(11):e577-e585. doi: 10.1016/S1470-2045(25)00434-6.
2
New power in cancer immunotherapy: the rise of chimeric antigen receptor macrophage (CAR-M).癌症免疫疗法的新力量：嵌合抗原受体巨噬细胞（CAR-M）的崛起。
J Transl Med. 2025 Oct 28;23(1):1182. doi: 10.1186/s12967-025-07115-9.
3
Neurologic complications of immune checkpoint inhibitors: A comprehensive review.
Biomed Pharmacother. 2025 Nov;192:118669. doi: 10.1016/j.biopha.2025.118669. Epub 2025 Oct 24.
4
Current Role of CAR-T Therapy in Haematological Care.
Adv Exp Med Biol. 2025;1486:193-216. doi: 10.1007/978-3-031-97297-3_16.
5
Advancing Cancer Immunotherapy Using Lipid Nanoparticle-Based Approaches.
Int J Nanomedicine. 2025 Oct 8;20:12283-12305. doi: 10.2147/IJN.S541061. eCollection 2025.
6
Recent advances in adoptive cell therapy for cancer immunotherapy.
Front Immunol. 2025 Sep 22;16:1665488. doi: 10.3389/fimmu.2025.1665488. eCollection 2025.
7
Overcoming resistance to anti-PD-L1 immunotherapy: mechanisms, combination strategies, and future directions.克服抗程序性死亡配体1免疫疗法的耐药性：机制、联合策略及未来方向
Mol Cancer. 2025 Oct 8;24(1):246. doi: 10.1186/s12943-025-02400-z.
8
Novel PD-L1 Small-Molecule Inhibitors Advancing Cancer Immunotherapy.新型PD-L1小分子抑制剂推动癌症免疫疗法发展。
Anticancer Agents Med Chem. 2025 Oct 3. doi: 10.2174/0118715206393267250912114756.
9
Reprogramming cellular senescence and aging clocks for advanced cancer immunotherapy.为先进的癌症免疫疗法重编程细胞衰老和老化时钟。
Mol Cancer. 2025 Oct 2;24(1):237. doi: 10.1186/s12943-025-02459-8.
10
Optimizing CAR T cell therapy for solid tumours: a clinical perspective.优化实体瘤的嵌合抗原受体T细胞疗法：临床视角
Nat Rev Clin Oncol. 2025 Oct 2. doi: 10.1038/s41571-025-01075-1.